Early initiation of antiretroviral therapy following in utero HIV infection is associated with low viral reservoirs but other factors determine subsequent plasma viral rebound.

The Journal of Infectious Diseases
Jane R MillarPhilip Goulder

Abstract

Early HIV diagnosis allows combination antiretroviral therapy (cART) initiation in the first days of life following in utero (IU) infection. The impact of early cART initiation on infant viral reservoir size in the setting of high-frequency cART non-adherence is unknown. Peripheral blood total HIV DNA from 164 early treated (day 0-21 of life) IU HIV-infected South African infants was measured using droplet digital PCR at birth and following suppressive cART. We evaluated the impact of cART initiation timing on HIV reservoir size and decay, and on the risk of subsequent plasma viraemia in cART-suppressed infants. Baseline HIV DNA (median 2.8 log10 copies/million PBMC, range 0.7 - 4.8) did not correlate with age at cART initiation (0-21 days) but instead with maternal antenatal cART use. In 98 infants with plasma viral suppression on cART, HIV DNA half-life was 28 days. However, the probability of maintenance of plasma aviraemia was low (0.46 at 12 months) and not influenced by HIV DNA load. Unexpectedly, longer time to viral suppression was associated with protection against subsequent viral rebound. With effective prophylaxis against mother-to-child transmission, cART initiation timing in the first 3 weeks of life is not critic...Continue Reading

References

Feb 28, 1997·Statistics in Medicine·R Tibshirani
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tobias R KollmannChristopher B Wilson
Feb 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel Scott-AlgaraFlorence Buseyne
Jul 8, 2011·The Pediatric Infectious Disease Journal·Tammy M MeyersHarry Moultrie
Oct 25, 2013·The New England Journal of Medicine·Deborah PersaudKatherine Luzuriaga
Sep 17, 2014·Clinical Pharmacokinetics·Shelley A McCormack, Brookie M Best
Jun 13, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta Martínez-BonetJavier Martinez-Picado
Mar 15, 2016·Nature Reviews. Immunology·Philip J GoulderEllen M Leitman
Mar 1, 2011·Journal of Statistical Software·Noah SimonRob Tibshirani
Jul 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hiromi ImamichiH Clifford Lane
Jul 28, 2016·EBioMedicine·Jintanat AnanworanichUNKNOWN RV217 and RV254/SEARCH010 study groups
Sep 24, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ragna S BoermaKim C E Sigaloff
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Priyanka UpretyUNKNOWN Pediatric HIV/AIDS Cohort Study (PHACS)
Apr 18, 2017·PloS One·Sara Morón-LópezJavier Martinez-Picado
May 11, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tim R CresseyUNKNOWN PHPT-5 study team
Jun 14, 2017·AIDS·Caroline FosterUNKNOWN CHERUB Investigators
Sep 12, 2017·The Journal of Clinical Investigation·Gert U Van ZylMary F Kearney
Jan 23, 2018·Open Forum Infectious Diseases·Mark D PankauDara A Lehman
May 10, 2018·The Lancet. HIV·Stephanie ShiauLouise Kuhn
Jun 19, 2018·The Journal of Clinical Investigation·D Brenda SalantesKatharine J Bar
Aug 11, 2018·Journal of the International AIDS Society·Chloe A TeasdaleElaine J Abrams
Mar 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ari BitnunUNKNOWN Early Pediatric Initiation Canada Child Cure Cohort (EPIC4) Research Group
Jun 14, 2019·The Pediatric Infectious Disease Journal·Shayla SmithMoherndran Archary
Aug 24, 2019·Journal of the International AIDS Society·Kirsten A VeldsmanGert U van Zyl
Jan 30, 2020·EClinicalMedicine·Louise KuhnUNKNOWN LEOPARD Study Team
Mar 7, 2020·Science Translational Medicine·Louise LeyreUNKNOWN RV254/SEARCH010, RV304/SEARCH013, SEARCH011 study groups

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.